X-110451780-C-T
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001385449.1(RTL9):c.1163C>T(p.Pro388Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000612 in 1,209,829 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001385449.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RTL9 | NM_001385449.1 | c.1163C>T | p.Pro388Leu | missense_variant | 3/4 | ENST00000520821.6 | NP_001372378.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RTL9 | ENST00000520821.6 | c.1163C>T | p.Pro388Leu | missense_variant | 3/4 | 4 | NM_001385449.1 | ENSP00000430395 | P1 | |
RTL9 | ENST00000465301.2 | c.1163C>T | p.Pro388Leu | missense_variant | 3/4 | 1 | ENSP00000419786 | P1 | ||
RTL9 | ENST00000540313.1 | c.1163C>T | p.Pro388Leu | missense_variant | 1/2 | 2 | ENSP00000441452 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000161 AC: 18AN: 111714Hom.: 0 Cov.: 24 AF XY: 0.000118 AC XY: 4AN XY: 33916
GnomAD3 exomes AF: 0.000104 AC: 19AN: 183319Hom.: 0 AF XY: 0.0000590 AC XY: 4AN XY: 67771
GnomAD4 exome AF: 0.0000510 AC: 56AN: 1098061Hom.: 0 Cov.: 33 AF XY: 0.0000550 AC XY: 20AN XY: 363415
GnomAD4 genome AF: 0.000161 AC: 18AN: 111768Hom.: 0 Cov.: 24 AF XY: 0.000118 AC XY: 4AN XY: 33980
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 05, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at